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Nipah virus (NiV) is a member of the family Paramyxoviridae, genus Henipavirus. NiV was initially isolated and identified in 1999 
during an outbreak of encephalitis and respiratory illness among pig farmers and people with close contact with pigs in Malaysia 
and Singapore. Its name originated from Sungai Nipah, a village in the Malaysian Peninsula where pig farmers became ill with 
encephalitis. Given the relatedness of NiV to Hendra virus, bat species were quickly singled out for investigation and flying foxes of 
the genus Pteropus were subsequently identified as the reservoir for NiV (Distribution Map). 
In the 1999 outbreak, Nipah virus caused a relatively mild disease in pigs, but nearly 300 human cases with over 100 deaths were 
reported. In order to stop the outbreak, more than a million pigs were euthanized, causing tremendous trade loss for Malaysia. 
Since this outbreak, no subsequent cases (in neither swine nor human) have been reported in either Malaysia or Singapore. 
In 2001, NiV was again identified as the causative agent in an outbreak of human disease occurring in Bangladesh. Genetic 
sequencing confirmed this virus as Nipah virus, but a strain different from the one identified in 1999. In the same year, another 
outbreak was identified retrospectively in Siliguri, India with reports of person-to-person transmission in hospital settings 
(nosocomial transmission). Unlike the Malaysian NiV outbreak, outbreaks occur almost annually in Bangladesh and have been 
reported several times in India. 
Transmission 
Transmission of Nipah virus to humans may occur after direct contact with infected bats, infected pigs, or from other NiV infected 
people. 
In Malaysia and Singapore, humans were apparently infected with Nipah virus only through close contact with infected pigs. The 
NiV strain identified in this outbreak appeared to have been transmitted initially from bats to pigs, with subsequent spread within pig 
populations. Incidental human infections resulted after exposure to infected pigs. No occurrence of person-to-person transmission 
was reported in this outbreak. 
Conversely, person-to-person transmission of Nipah virus in Bangladesh and India is regularly reported. This is most commonly 
seen in the family and caregivers of Nipah virus-infected patients. Transmission also occurs from direct exposure to infected bats. A 
common example is consumption of raw date palm sap contaminated with infectious bat excretions. 
Signs and Symptoms 
Infection with Nipah virus is associated with encephalitis (inflammation of the brain). After exposure and an incubation period of 5 to 
14 days,illness presents with 3-14 days of fever and headache, followed by drowsiness, disorientation and mental confusion. These 
signs and symptoms can progress to coma within 24-48 hours. Some patients have a respiratory illness during the early part of their 
infections, and half of the patients showing severe neurological signs showed also pulmonary signs. 
During the Nipah virus disease outbreak in 1998-99, 265 patients were infected with the virus. About 40% of those patients who 
entered hospitals with serious nervous disease died from the illness. 
Long-term sequelae following Nipah virus infection have been noted, including persistent convulsions and personality changes. 
Latent infections with subsequent reactivation of Nipah virus and death have also been reported months and even years after 
exposure. 
Risk of Exposure 
In the Malaysia and Singapore outbreak, Nipah virus infection was associated with close contact with Nipah virus-infected pigs. 
In Bangladesh and India, where Nipah virus infection is more frequent, exposure has been linked to consumption of raw date palm 
sap and contact with bats. Importantly, human-to-human transmission has been documented and exposure to other Nipah virus 
infected individuals is also a risk factor. 
Diagnosis 
Laboratory diagnosis of a patient with a clinical history of NiV can be made during the acute and convalescent phases of the 
disease by using a combination of tests.  Virus isolation attempts and real time polymerase chain reaction (RT-PCR) from throat 
and nasal swabs, cerebrospinal fluid, urine, and blood should be performed in the early stages of disease. Antibody detection by 
ELISA (IgG and IgM) can be used later on. In fatal cases, immunohistochemistry on tissues collected during autopsy may be the 
only way to confirm a diagnosis. 
Treatment 
Treatment is limited to supportive care. Because Nipah virus encephalitis can be transmitted person-to-person, standard infection  
 
 
control practices and proper barrier nursing techniques are important in preventing hospital-acquired infections (nosocomial 
transmission). 
The drug ribavirin has been shown to be effective against the viruses in vitro, but human investigations to date have been 
inconclusive and the clinical usefulness of ribavirin remains uncertain. 
Passive immunization using a human monoclonal antibody targeting the Nipah G glycoprotein has been evaluated in the post-
exposure therapy in the ferret model and found to be of benefit.  
Prevention 
Nipah virus infection can be prevented by avoiding exposure to sick pigs and bats in endemic areas and not drinking raw date palm 
sap. 
Additional efforts focused on surveillance and awareness will help prevent future outbreaks. Research is needed to better 
understand the ecology of bats and Nipah virus, investigating questions such as the seasonality of disease within reproductive 
cycles of bats. Surveillance tools should include reliable laboratory assays for early detection of disease in communities and 
livestock, and raising awareness of transmission and symptoms is important in reinforcing standard infection control practices to 
avoid human-to-human infections in hospital settings (nosocomial). 
A subunit vaccine, using the Hendra G protein, produces cross-protective antibodies against HENV and NIPV has been recently 
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